You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Treatment: Relenza (zanamivir) is indicated for the treatment of infections due to Influenza A and B viruses in adults and children aged 5 years and older. Treatment should commence as soon as possible but no later than forty-eight hours after the onset of the initial symptoms of infection (see Precautions). Prophylaxis: Vaccination remains the primary method of preventing and controlling influenza. Relenza is indicated for prophylaxis of Influenza A and B in adults and children (5 years and older) to reduce transmission among individuals in households with an infected person. Relenza is indicated for prophylaxis of influenza A and B during community outbreaks only in circumstances where such prophylaxis is justified (such as when vaccine that antigenically matches circulating influenza is not available or there is a pandemic). It is not recommended for routine prophylaxis against influenza infection.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Treatment: Relenza (zanamivir) is indicated for the treatment of infections due to Influenza A and B viruses in adults and children aged 5 years and older. Treatment should commence as soon as possible but no later than forty-eight hours after the onset of the initial symptoms of infection (see Precautions). Prophylaxis: Vaccination remains the primary method of preventing and controlling influenza. Relenza is indicated for prophylaxis of Influenza A and B in adults and children (5 years and older) to reduce transmission among individuals in households with an infected person. Relenza is indicated for prophylaxis of influenza A and B during community outbreaks only in circumstances where such prophylaxis is justified (such as when vaccine that antigenically matches circulating influenza is not available or there is a pandemic). It is not recommended for routine prophylaxis against influenza infection.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Treatment: Relenza (zanamivir) is indicated for the treatment of infections due to Influenza A and B viruses in adults and children aged 5 years and older. Treatment should commence as soon as possible but no later than forty-eight hours after the onset of the initial symptoms of infection (see Precautions). Prophylaxis: Vaccination remains the primary method of preventing and controlling influenza. Relenza is indicated for prophylaxis of Influenza A and B in adults and children (5 years and older) to reduce transmission among individuals in households with an infected person. Relenza is indicated for prophylaxis of influenza A and B during community outbreaks only in circumstances where such prophylaxis is justified (such as when vaccine that antigenically matches circulating influenza is not available or there is a pandemic). It is not recommended for routine prophylaxis against influenza infection.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Treatment: Relenza (zanamivir) is indicated for the treatment of infections due to Influenza A and B viruses in adults and children aged 5 years and older. Treatment should commence as soon as possible but no later than forty-eight hours after the onset of the initial symptoms of infection (see Precautions). Prophylaxis: Vaccination remains the primary method of preventing and controlling influenza. Relenza is indicated for prophylaxis of Influenza A and B in adults and children (5 years and older) to reduce transmission among individuals in households with an infected person. Relenza is indicated for prophylaxis of influenza A and B during community outbreaks only in circumstances where such prophylaxis is justified (such as when vaccine that antigenically matches circulating influenza is not available or there is a pandemic). It is not recommended for routine prophylaxis against influenza infection.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
